Upjohn US 1 LLC
Records under this name other than patents Upjohn US 1 LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,875,731 | Salt Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-BETA, DELTA-DIHYDROXY-5-1-Methylethyl)-3-Phenyl-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-Heptanoic Acid Formerly held In force · High confidence | In force | High confidence | |
| US 8,026,376 | Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoicacid calcium salt (2:1) Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,939,675 | Process for forming amorphous atorvastatin Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,084,488 | Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,079,877 | Process for Preparing Chiral Compounds Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,642,783 | Process for preparing chiral compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,034,913 | Process for annealing amorphous atorvastatin Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,383,667 | Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium Formerly held In force Term ended Nov 9, 2026 · From the USPTO record | In force | Term ended Nov 9, 2026 | From the USPTO record |
| US 8,945,620 | Solid Pharmaceutical Compositions Containing Pregabalin Formerly held Term ended Term ended Nov 2, 2026 · Medium confidence | Term ended | Term ended Nov 2, 2026 | Medium confidence |
| US 9,144,559 | Solid Pharmaceutical Compositions Containing Pregabalin Formerly held Term ended Term ended Nov 2, 2026 · Medium confidence | Term ended | Term ended Nov 2, 2026 | Medium confidence |